The Ensign Group (NASDAQ:ENSG) Releases FY 2026 Earnings Guidance

The Ensign Group (NASDAQ:ENSG) issued an update on its FY 2026 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 7.750-7.850 for the period, compared to the consensus estimate of 7.410. The company issued revenue guidance of $5.9 billion-$5.9 billion, compared to the consensus revenue estimate of $5.8 billion.

Wall Street Analyst Weigh In

ENSG has been the subject of a number of research analyst reports. Truist Financial reduced their price objective on shares of The Ensign Group from $215.00 to $202.00 and set a “hold” rating for the company in a research report on Tuesday, July 14th. Weiss Ratings cut shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Wall Street Zen cut The Ensign Group from a “buy” rating to a “hold” rating in a report on Saturday. Royal Bank Of Canada reissued an “outperform” rating on shares of The Ensign Group in a report on Tuesday, June 9th. Finally, Zacks Research lowered The Ensign Group from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, The Ensign Group has an average rating of “Moderate Buy” and a consensus price target of $213.50.

The Ensign Group Price Performance

ENSG stock opened at $172.99 on Monday. The Ensign Group has a 1 year low of $141.58 and a 1 year high of $218.00. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.56 and a quick ratio of 1.56. The stock has a market cap of $10.11 billion, a price-to-earnings ratio of 28.17, a P/E/G ratio of 1.69 and a beta of 0.69. The company has a 50 day simple moving average of $165.30 and a 200 day simple moving average of $183.91.

The Ensign Group (NASDAQ:ENSG) last announced its quarterly earnings results on Monday, July 27th. The company reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.12. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Research analysts anticipate that The Ensign Group will post 6.82 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Tuesday, June 30th. The Ensign Group’s dividend payout ratio (DPR) is 4.23%.

Insiders Place Their Bets

In other The Ensign Group news, Director Barry M. Smith sold 700 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total value of $114,996.00. Following the completion of the transaction, the director directly owned 21,352 shares in the company, valued at approximately $3,507,706.56. This represents a 3.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.00% of the stock is owned by insiders.

Hedge Funds Weigh In On The Ensign Group

A number of hedge funds have recently made changes to their positions in ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in The Ensign Group by 9.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after acquiring an additional 14,590 shares during the last quarter. Geneos Wealth Management Inc. boosted its stake in shares of The Ensign Group by 150.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after purchasing an additional 230 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of The Ensign Group by 65.9% during the second quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock worth $83,000 after buying an additional 213 shares during the period. Amundi raised its stake in The Ensign Group by 480,216.7% during the second quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after buying an additional 57,626 shares during the last quarter. Finally, Brown Advisory Inc. boosted its position in The Ensign Group by 26.1% during the second quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock valued at $314,000 after acquiring an additional 421 shares during the last quarter. 96.12% of the stock is currently owned by institutional investors.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.